608 related articles for article (PubMed ID: 3027168)
21. Lack of cross-reaction in antibody-dependent cellular cytotoxicity between human immunodeficiency virus (HIV) and HIV-related West African strains.
Ljunggren K; Chiodi F; Biberfeld G; Norrby E; Jondal M; Fenyö EM
J Immunol; 1988 Jan; 140(2):602-5. PubMed ID: 3335784
[TBL] [Abstract][Full Text] [Related]
22. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
Lyerly HK; Reed DL; Matthews TJ; Langlois AJ; Ahearne PA; Petteway SR; Weinhold KJ
AIDS Res Hum Retroviruses; 1987; 3(4):409-22. PubMed ID: 2833917
[TBL] [Abstract][Full Text] [Related]
23. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
Böttiger B; Ljunggren K; Karlsson A; Krohn K; Fenyö EM; Jondal M; Biberfeld G
Clin Exp Immunol; 1988 Sep; 73(3):339-42. PubMed ID: 3208445
[TBL] [Abstract][Full Text] [Related]
24. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
Abe T
AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
[TBL] [Abstract][Full Text] [Related]
25. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP
Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134
[TBL] [Abstract][Full Text] [Related]
26. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
Nicholson JK; Cross GD; Callaway CS; McDougal JS
J Immunol; 1986 Jul; 137(1):323-9. PubMed ID: 3011909
[TBL] [Abstract][Full Text] [Related]
27. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
[TBL] [Abstract][Full Text] [Related]
28. Anti-class II antibodies in AIDS patients and AIDS-risk groups.
de la Barrera S; Fainboim L; Lugo S; Picchio GR; Muchinik GR; de Bracco MM
Immunology; 1987 Dec; 62(4):599-604. PubMed ID: 3501399
[TBL] [Abstract][Full Text] [Related]
29. Clinical and immunological findings in HTLV-III infection.
Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A
Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
[TBL] [Abstract][Full Text] [Related]
30. HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemia.
Robert-Guroff M; Giardina PJ; Robey WG; Jennings AM; Naugle CJ; Akbar AN; Grady RW; Hilgartner MW
J Immunol; 1987 Jun; 138(11):3731-6. PubMed ID: 3495568
[TBL] [Abstract][Full Text] [Related]
31. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
[TBL] [Abstract][Full Text] [Related]
32. The Walter Reed staging classification for HTLV-III/LAV infection.
Redfield RR; Wright DC; Tramont EC
N Engl J Med; 1986 Jan; 314(2):131-2. PubMed ID: 2934633
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 2 production in HTLV-III/LAV infection: evidence of defective antigen-induced, but normal mitogen-induced IL-2 production.
Antonen J; Krohn K
Clin Exp Immunol; 1986 Sep; 65(3):489-96. PubMed ID: 2946497
[TBL] [Abstract][Full Text] [Related]
34. Extrathecal and intrathecal IgG response to the AIDS virus LAV/HTLV-III in experimental infection of chimpanzees.
Goudsmit J; Gibbs CJ; Asher DM; Gajdusek DC
Cancer Detect Prev Suppl; 1987; 1():509-14. PubMed ID: 3480064
[TBL] [Abstract][Full Text] [Related]
35. Structural and epidemiological features of primate lymphotropic retroviruses.
Hunsmann G; Schneider J; Bayer H; Jurkiewicz E; Yamamoto N
Princess Takamatsu Symp; 1984; 15():109-18. PubMed ID: 6100632
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.
Casareale D; Dewhurst S; Sonnabend J; Sinangil F; Purtilo DT; Volsky DJ
AIDS Res; 1984-1985; 1(6):407-21. PubMed ID: 6085926
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma and HTLV-III: a study in Nigerian adult males.
Otu AA
J R Soc Med; 1986 Sep; 79(9):510-4. PubMed ID: 3021963
[TBL] [Abstract][Full Text] [Related]
38. Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs.
Tyler DS; Stanley SD; Bartlett JA; Bolognesi DP; Weinhold KJ
J Surg Res; 1998 Oct; 79(2):115-20. PubMed ID: 9758725
[TBL] [Abstract][Full Text] [Related]
39. T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses.
Zarling JM; Morton W; Moran PA; McClure J; Kosowski SG; Hu SL
Nature; 1986 Sep 25-Oct 1; 323(6086):344-6. PubMed ID: 3093891
[TBL] [Abstract][Full Text] [Related]
40. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]